Boston Children's Hospital joins TriNetX research network to connect patients with clinical trials

Boston Children's Hospital on Feb. 1 went live on TriNetX, a global health research network, to connect eligible patients with relevant clinical trials.

The TriNetX research network enables healthcare organizations, biopharmaceutical companies and contract research organizations to submit and analyze patient data. Each data point on the network can be traced to an individual healthcare organization, which may flag the patient for recruitment into relevant clinical trials.

Boston Children's Hospital officials hope the program will raise patient awareness of various clinical trials.

"Being part of the TriNetX network allows us to collaborate around the globe with other researchers at biopharmaceutical companies who are working on new therapies that our patients need," said Piotr Sliz, PhD, chief research information officer at Boston Children's Hospital.

More articles on data analytics & precision medicine:
Memorial Sloan Kettering invests in oncology startup Cota's Series C funding round
Cedars-Sinai researchers investigate 'patient-on-a-chip' tech to drive precision medicine
Report: Annual VC investment in genomics companies rises 142% since 2016

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Content

Featured Webinars

Featured Whitepapers